Literature DB >> 26074705

Proportions of acetyl-histone-positive hepatocytes indicate the functional status and prognosis of cirrhotic patients.

Ping Zhou1, Jie Xia1, Yong-Jie Zhou1, Jun Wan1, Li Li1, Ji Bao1, Yu-Jun Shi1, Hong Bu1.   

Abstract

AIM: To investigate whether the proportions of acetyl-histone-positive hepatocytes could be used as markers of deteriorating liver function.
METHODS: In total, 611 cirrhotic cases from 3701 patients who were diagnosed during the past 15 years were screened, and 152 follow-up cases were selected. Paraffin tissue microarray was prepared for immunohistochemistry to examine acetyl-histone expression. The proportions of positive hepatocytes were recorded, and their correlations to clinical and laboratory indicators were analyzed statistically.
RESULTS: The proportions of H2AK5ac(+), H3K9/K14ac(+) and H3K27ac(+) hepatocytes gradually increased with deteriorating liver function and with increasing levels of serum markers of liver injury. In the follow-up cases, patients with > 70% H2AK5ac(+), H3K9/K14ac(+) or H3K27ac(+) hepatocytes had statistically lower survival rates (P < 0.05). Furthermore, > 70% H2AK5ac(+) or H3K27ac(+) hepatocytes were strong independent predictors of overall survival (P < 0.05).
CONCLUSION: The proportions of acetyl-histone-positive hepatocytes are closely associated with the liver function and prognosis of cirrhotic patients.

Entities:  

Keywords:  Cirrhosis; Histone acetylation; Liver function; Prognosis

Mesh:

Substances:

Year:  2015        PMID: 26074705      PMCID: PMC4458777          DOI: 10.3748/wjg.v21.i21.6665

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Role of histone acetylation in cell physiology and diseases: An update.

Authors:  Shahper N Khan; Asad U Khan
Journal:  Clin Chim Acta       Date:  2010-06-23       Impact factor: 3.786

2.  Acetylation/deacetylation modulates the stability of DNA replication licensing factor Cdt1.

Authors:  Michele A Glozak; Edward Seto
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

Review 3.  The development and potential clinical utility of biomarkers for HDAC inhibitors.

Authors:  Baowen Shi; Wenfang Xu
Journal:  Drug Discov Ther       Date:  2013-08

4.  Activation of inactive hepatocytes through histone acetylation: a mechanism for functional compensation after massive loss of hepatocytes.

Authors:  Yujun Shi; Huaiqiang Sun; Ji Bao; Ping Zhou; Jie Zhang; Li Li; Hong Bu
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

Review 5.  Histone deacetylases and cancer.

Authors:  Bruna Barneda-Zahonero; Maribel Parra
Journal:  Mol Oncol       Date:  2012-08-27       Impact factor: 6.603

Review 6.  Histone deacetylases as targets for treatment of multiple diseases.

Authors:  Jinhua Tang; Haidong Yan; Shougang Zhuang
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

Review 7.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

8.  Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment.

Authors:  Michael C Kew
Journal:  World J Hepatol       Date:  2012-03-27

9.  In-hospital mortality among a cohort of cirrhotic patients admitted to a tertiary hospital.

Authors:  Mohammad A Alsultan; Rashed S Alrshed; Abdulrahman A Aljumah; Salim A Baharoon; Yaseen M Arabi; Abdulaziz S Aldawood
Journal:  Saudi J Gastroenterol       Date:  2011 Nov-Dec       Impact factor: 2.485

Review 10.  Pre-clinical studies of epigenetic therapies targeting histone modifiers in lung cancer.

Authors:  Kenneth Huffman; Elisabeth D Martinez
Journal:  Front Oncol       Date:  2013-09-09       Impact factor: 6.244

View more
  4 in total

1.  Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis.

Authors:  Xiaoli Yang; Yan Liu; Menghui Li; Hao Wu; Yunbing Wang; Yu You; Peizhi Li; Xiong Ding; Chang'an Liu; Jianping Gong
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

Review 2.  Role of Histone Post-Translational Modifications in Inflammatory Diseases.

Authors:  Yingying Lin; Ting Qiu; Guifeng Wei; Yueyue Que; Wenxin Wang; Yichao Kong; Tian Xie; Xiabin Chen
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

Review 3.  Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview.

Authors:  Mohd Suhail; Sayed Sartaj Sohrab; Mohammad Amjad Kamal; Esam Ibraheem Azhar
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

Review 4.  Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC).

Authors:  Pin Zhao; Samiullah Malik; Shaojun Xing
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.